These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 9397242)

  • 21. Blocking effects of OPC-21268 and OPC-31260 (vasopressin V1- and V2-receptor antagonists) on vasopressin-induced constrictions in isolated, perfused dog femoral arteries.
    Chiba S; Tsukada M
    Jpn J Pharmacol; 1992 May; 59(1):133-5. PubMed ID: 1324373
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of nonpeptide and selective V1 and V2 antagonists on blood pressure short-term variability in spontaneously hypertensive rats.
    Japundzić-Zigon N; Milutinović S; Jovanović A
    J Pharmacol Sci; 2004 May; 95(1):47-55. PubMed ID: 15153650
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of novel, nonpeptide vasopressin antagonists on progressive nephrosclerosis in rats.
    Okada H; Suzuki H; Kanno Y; Saruta T
    J Cardiovasc Pharmacol; 1995 May; 25(5):847-52. PubMed ID: 7630164
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of nonpeptide vasopressin receptor antagonists on developing, and established DOCA-salt hypertension in rats.
    Okada H; Suzuki H; Kanno Y; Saruta T
    Clin Exp Hypertens; 1995 Apr; 17(3):469-83. PubMed ID: 7613523
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronic and selective vasopressin blockade in spontaneously hypertensive rats.
    Okada H; Suzuki H; Kanno Y; Yamamura Y; Saruta T
    Am J Physiol; 1994 Dec; 267(6 Pt 2):R1467-71. PubMed ID: 7810754
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of vasopressin action in vascular smooth muscle by the V1 antagonist OPC-21268.
    Li X; Kribben A; Wieder ED; Tsai P; Nemenoff RA; Schrier RW
    Hypertension; 1994 Feb; 23(2):217-22. PubMed ID: 8307632
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Different cellular mechanisms of vasopressin receptor V1 and V2 subtype in vasopressin-induced adenosine 3', 5'-monophosphate formation in an immortalized renal tubule cell line, TKC2.
    Takeuchi K; Yanai N; Takahashi N; Abe T; Tsutsumi E; Obinata M; Abe K
    Biochem Biophys Res Commun; 1994 Jul; 202(2):680-7. PubMed ID: 8048937
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dietary Na and baroreflex modulation of blood pressure and RSNA in normotensive vs. spontaneously hypertensive rats.
    Huang BS; Leenen FH
    Am J Physiol; 1994 Feb; 266(2 Pt 2):H496-502. PubMed ID: 8141350
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of OPC-21268, an orally effective vasopressin V1 receptor antagonist in humans.
    Imaizumi T; Harada S; Hirooka Y; Masaki H; Momohara M; Takeshita A
    Hypertension; 1992 Jul; 20(1):54-8. PubMed ID: 1319959
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potent antagonistic action of OPC-31260, a vasopressin V2 receptor antagonist, on [Arg8]vasopressin-induced vasoconstriction in isolated simian femoral arteries.
    Chiba S; Tsukada M
    Eur J Pharmacol; 1992 Oct; 221(2-3):393-5. PubMed ID: 1330628
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Vasopressin (ADH)].
    Hirai A; Uchida D; Yoshida S
    Nihon Rinsho; 1992 Dec; 50(12):2893-900. PubMed ID: 1337114
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of oral AVP receptor antagonists OPC-21268 and OPC-31260 on congestive heart failure in conscious dogs.
    Naitoh M; Suzuki H; Murakami M; Matsumoto A; Arakawa K; Ichihara A; Nakamoto H; Oka K; Yamamura Y; Saruta T
    Am J Physiol; 1994 Dec; 267(6 Pt 2):H2245-54. PubMed ID: 7810724
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protective effect of a vasopressin-1 selective antagonist, OPC-21268, against ethanol-induced damage of the rat gastric wall.
    Sugimoto I; Narimiya N; Odagiri M; Ohnishi A; Tanaka T
    Dig Dis Sci; 1999 Mar; 44(3):503-9. PubMed ID: 10080141
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of nonpeptide V1a and V2 antagonists on blood pressure fast oscillations in conscious rats.
    Japundzic-Zigon N
    Clin Exp Hypertens; 2001 May; 23(4):277-92. PubMed ID: 11349820
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of brain edema with a nonpeptide arginine vasopressin V1 receptor antagonist OPC-21268 in rats.
    Bemana I; Nagao S
    Neurosurgery; 1999 Jan; 44(1):148-54; discussion 154-5. PubMed ID: 9894975
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heart rate and blood pressure variabilities in salt-sensitive hypertension.
    Piccirillo G; Bucca C; Durante M; Santagada E; Munizzi MR; Cacciafesta M; Marigliano V
    Hypertension; 1996 Dec; 28(6):944-52. PubMed ID: 8952581
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiovascular, endocrine, and body fluid-electrolyte responses to salt loading in mRen-2 transgenic rats.
    Li P; Morris M; Ferrario CM; Barrett C; Ganten D; Callahan MF
    Am J Physiol; 1998 Oct; 275(4):H1130-7. PubMed ID: 9746459
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A lack of anti-hypertensive effect of an orally effective V1 receptor antagonist, OPC-21268, in end-stage renal disease.
    Nakayama M; Yamada K; Nakano H; Miura Y; Suzuki S; Tuchida H; Yoshida S
    Clin Nephrol; 1993 Jul; 40(1):58-9. PubMed ID: 8395368
    [No Abstract]   [Full Text] [Related]  

  • 39. Effects of Long-term Blockade of Vasopressin Receptor Types 1a and 2 on Cardiac and Renal Damage in a Rat Model of Hypertensive Heart Failure.
    Ikeda T; Iwanaga Y; Watanabe H; Morooka H; Akahoshi Y; Fujiki H; Miyazaki S
    J Cardiovasc Pharmacol; 2015 Nov; 66(5):487-96. PubMed ID: 26248278
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of OPC-21268, an oral, nonpeptide arginine vasopressin V1 receptor antagonist, on a patient with congestive heart failure.
    Miura Y; Yamada K; Nakayama M; Nakano H; Suzuki S; Tsuchida H; Yoshida S
    Clin Nephrol; 1993 Jul; 40(1):60-1. PubMed ID: 8395369
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.